chemotherapy

Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial
Raghav Sundar, Nesaretnam Barr Kumarakulasinghe, Yiong Huak Chan, Kazuhiro Yoshida, Takaki Yoshikawa, Yohei Miyagi, Yasushi Rino, Munetaka Masuda, Jia Guan, Junichi Sakamoto, Shiro Tanaka, Angie Lay-Keng Tan, Michal Marek Hoppe, Anand D. Jeyasekharan, Cedric Chuan Young Ng, Mark De Simone, Heike I. Grabsch, Jeeyun Lee, Takashi Oshima, Akira Tsuburaya, Patrick Tan

Gut Apr 2022, 71 (4) 676-685; DOI: 10.1136/gutjnl-2021-324060
Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans
D M K Keefe, J Brealey, G J Goland, A G Cummins

Gut Nov 2000, 47 (5) 632-637; DOI: 10.1136/gut.47.5.632
Response to: ‘Unified definition of relapse-free survival should be used for evaluating survival benefit in oesophageal adenocarcinoma’ by Li
Anita Lavery, Jaine K Blayney, Richard C Turkington

Gut Mar 2021, 70 (3) 626; DOI: 10.1136/gutjnl-2020-322096
Unified definition of relapse-free survival should be used for evaluating survival benefit in oesophageal adenocarcinoma
Weizheng Li

Gut Jan 2021, 70 (1) 228; DOI: 10.1136/gutjnl-2020-321482
Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab
Anthony Dohan, Benoit Gallix, Boris Guiu, Karine Le Malicot, Caroline Reinhold, Philippe Soyer, Jaafar Bennouna, Francois Ghiringhelli, Emilie Barbier, Valérie Boige, Julien Taieb, Olivier Bouché, Eric François, Jean-Marc Phelip, Christian Borel, Roger Faroux, Jean-Francois Seitz, Stéphane Jacquot, Meher Ben Abdelghani, Faiza Khemissa-Akouz, Dominique Genet, Jean Louis Jouve, Yves Rinaldi, Françoise Desseigne, Patrick Texereau, Etienne Suc, Come Lepage, Thomas Aparicio, Christine Hoeffel

Gut Mar 2020, 69 (3) 531-539; DOI: 10.1136/gutjnl-2018-316407
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
Richard C Turkington, Laura A Knight, Jaine K Blayney, Maria Secrier, Rosalie Douglas, Eileen E Parkes, Eilis K Sutton, Leanne Stevenson, Damian McManus, Sophia Halliday, Andrena M McCavigan, Gemma E Logan, Steven M Walker, Christopher J Steele, Juliane Perner, Jan Bornschein, Shona MacRae, Ahmad Miremadi, Eamon McCarron, Stephen McQuaid, Kenneth Arthur, Jacqueline A James, Martin M Eatock, Robert O’Neill, Fergus Noble, Timothy J Underwood, D Paul Harkin, Manuel Salto-Tellez, Rebecca C Fitzgerald, Richard D Kennedy

Gut Nov 2019, 68 (11) 1918-1927; DOI: 10.1136/gutjnl-2018-317624
Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer
Ludovic Barault, Alessio Amatu, Giulia Siravegna, Agostino Ponzetti, Sebastian Moran, Andrea Cassingena, Benedetta Mussolin, Chiara Falcomatà, Alexandra M Binder, Carmen Cristiano, Daniele Oddo, Simonetta Guarrera, Carlotta Cancelliere, Sara Bustreo, Katia Bencardino, Sean Maden, Alice Vanzati, Patrizia Zavattari, Giuseppe Matullo, Mauro Truini, William M Grady, Patrizia Racca, Karin B Michels, Salvatore Siena, Manel Esteller, Alberto Bardelli, Andrea Sartore-Bianchi, Federica Di Nicolantonio

Gut Nov 2018, 67 (11) 1995-2005; DOI: 10.1136/gutjnl-2016-313372
Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study
Jeanne Tie, Joshua D Cohen, Yuxuan Wang, Lu Li, Michael Christie, Koen Simons, Hany Elsaleh, Suzanne Kosmider, Rachel Wong, Desmond Yip, Margaret Lee, Ben Tran, David Rangiah, Matthew Burge, David Goldstein, Madhu Singh, Iain Skinner, Ian Faragher, Matthew Croxford, Carolyn Bampton, Andrew Haydon, Ian T Jones, Christos S Karapetis, Timothy Price, Mary J Schaefer, Jeanne Ptak, Lisa Dobbyn, Natallie Silliman, Isaac Kinde, Cristian Tomasetti, Nickolas Papadopoulos, Kenneth Kinzler, Bert Volgestein, Peter Gibbs

Gut Apr 2019, 68 (4) 663-671; DOI: 10.1136/gutjnl-2017-315852
CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells
Gwenola Manic, Michele Signore, Antonella Sistigu, Giorgio Russo, Francesca Corradi, Silvia Siteni, Martina Musella, Sara Vitale, Maria Laura De Angelis, Matteo Pallocca, Carla Azzurra Amoreo, Francesca Sperati, Simone Di Franco, Sabina Barresi, Eleonora Policicchio, Gabriele De Luca, Francesca De Nicola, Marcella Mottolese, Ann Zeuner, Maurizio Fanciulli, Giorgio Stassi, Marcello Maugeri-Saccà, Marta Baiocchi, Marco Tartaglia, Ilio Vitale, Ruggero De Maria

Gut May 2018, 67 (5) 903-917; DOI: 10.1136/gutjnl-2016-312623
Tailoring the colorectal cancer disease assessment to the treatment strategy
Dustin A Deming

Gut Jun 2018, 67 (6) 996-997; DOI: 10.1136/gutjnl-2017-315394

Main menu

chemotherapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

chemotherapy

Pages